These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6424457)
21. Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes. Eibl MM; Cairns L; Rosen FS Clin Immunol Immunopathol; 1984 Apr; 31(1):151-60. PubMed ID: 6421524 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of primary immunodeficiencies with intravenous gamma globulin]. García Rodríguez C; López Trascasa M; Ferreira Cerdán A; Fontán Casariego G An Esp Pediatr; 1987 Dec; 27(6):411-5. PubMed ID: 2451892 [TBL] [Abstract][Full Text] [Related]
23. Slow subcutaneous immunoglobulin therapy in a patient with reactions to intramuscular immunoglobulin. Welch MJ; Stiehm ER J Clin Immunol; 1983 Jul; 3(3):285-6. PubMed ID: 6885970 [TBL] [Abstract][Full Text] [Related]
24. Replacement therapy with modified immunoglobulin G in burn patients: preliminary kinetic studies. Shirani KZ; Vaughan GM; McManus AT; Amy BW; McManus WF; Pruitt BA; Mason AD Am J Med; 1984 Mar; 76(3A):175-80. PubMed ID: 6424447 [TBL] [Abstract][Full Text] [Related]
25. Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency. Schiff RI Vox Sang; 1985; 49 Suppl 1():15-24. PubMed ID: 2416124 [TBL] [Abstract][Full Text] [Related]
26. Adverse reactions in selected patients following intravenous infusions of gamma globulin. Day NK; Good RA; Wahn V Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860 [TBL] [Abstract][Full Text] [Related]
27. Intramuscular and intravenous administration of immunoglobulin to patients with hypogammaglobulinemia. Hanson LA; Björkander J; Wadsworth C Birth Defects Orig Artic Ser; 1983; 19(3):205-7. PubMed ID: 6652239 [TBL] [Abstract][Full Text] [Related]
28. Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin. Ballow M; White W; Desbonnet C J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):595-601; discussion 601-2. PubMed ID: 2571628 [TBL] [Abstract][Full Text] [Related]
29. Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults. Oral A; Nusbacher J; Hill JB; Lewis JH Am J Med; 1984 Mar; 76(3A):187-92. PubMed ID: 6424449 [TBL] [Abstract][Full Text] [Related]
30. Normalization of serum C1q after intravenous immunoglobulin infusions in hypogammaglobulinemia: dependence upon methods of immunoglobulin preparation. Cunningham-Rundles C Clin Immunol Immunopathol; 1984 Nov; 33(2):176-81. PubMed ID: 6207968 [TBL] [Abstract][Full Text] [Related]
31. [Substitution with immunoglobulins in primary antibody deficiency syndrome]. Morell A; Barandun S Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383 [No Abstract] [Full Text] [Related]
32. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Eijkhout HW; van Der Meer JW; Kallenberg CG; Weening RS; van Dissel JT; Sanders LA; Strengers PF; Nienhuis H; Schellekens PT; Ann Intern Med; 2001 Aug; 135(3):165-74. PubMed ID: 11487483 [TBL] [Abstract][Full Text] [Related]
33. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. Weeks JC; Tierney MR; Weinstein MC N Engl J Med; 1991 Jul; 325(2):81-6. PubMed ID: 1904989 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Cunningham-Rundles C; Siegal FP; Smithwick EM; Lion-Boulé A; Cunningham-Rundles S; O'Malley J; Barandun S; Good RA Ann Intern Med; 1984 Oct; 101(4):435-9. PubMed ID: 6206756 [TBL] [Abstract][Full Text] [Related]
35. IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients. Williams PE; Leen CL; Heppleston AD; Yap PL Blut; 1990 Mar; 60(3):198-201. PubMed ID: 2317569 [TBL] [Abstract][Full Text] [Related]
36. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Liese JG; Wintergerst U; Tympner KD; Belohradsky BH Am J Dis Child; 1992 Mar; 146(3):335-9. PubMed ID: 1543181 [TBL] [Abstract][Full Text] [Related]
37. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Roifman CM; Lederman HM; Lavi S; Stein LD; Levison H; Gelfand EW Am J Med; 1985 Aug; 79(2):171-4. PubMed ID: 4025374 [TBL] [Abstract][Full Text] [Related]
38. Intravenous immune globulin: dosage and administration. Wordell CJ Pharmacotherapy; 1987; 7(2):S27-30. PubMed ID: 3299297 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation. Bernatowska E; Weremowicz R; Janowicz W; Madaliński K Arch Immunol Ther Exp (Warsz); 1986; 34(4):377-84. PubMed ID: 3099724 [TBL] [Abstract][Full Text] [Related]
40. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases. Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]